HEALTHCARE IT

CLINICAL RESEARCH

BTK Inhibition in CLL: Comparing Brukinsa and Jaypirca Approaches

Chronic lymphocytic leukemia (CLL) is among the most prevalent leukemias in adults, which is a disease of slowly accumulated malignant B lymphocytes. A shift...

SEQUOIA Trial 6-Year Data on Zanubrutinib in del(17p) CLL Patients

Background Deletion 17p, written del(17p), is a high risk cytogenetic change in chronic lymphocytic leukemia, or CLL. Patients with del(17p) tend to do poorly with...

EHR

MEDICAL DEVICE

FEATURED ARTICLE

POPULAR POSTS

PATIENT ENGAGEMENT & PORTALS

FROM THE BLOG